Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice

BACKGROUND: Exenatide is an insulinotropic peptide drug for type 2 diabetes treatment with low risk of hypoglycemia, and is administrated by subcutaneous injection. Oral administration is the most preferred route for lifelong treatment of diabetes, but oral delivery of peptide drug remains a signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Xiaoyan, Qian, Kang, Yao, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189518/
https://www.ncbi.nlm.nih.gov/pubmed/32345323
http://dx.doi.org/10.1186/s12951-020-00619-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189518/
https://www.ncbi.nlm.nih.gov/pubmed/32345323
http://dx.doi.org/10.1186/s12951-020-00619-0

Ejemplares similares